Inogen, Inc. (INGN) has a MoatMap StockRank of 61/100 based on Quality (49/100), Value (51/100), and Momentum (46/100) factor scores. The current signal is HOLD. Inogen, a healthcare company, operates in the specialized portable oxygen concentrator market. While healthcare is generally defensive, there is no direct or asymmetric macro tailwind from the identified themes that would create a high-conviction opportunity. This is a highly specific product-driven story requiring deep product and market diligence.
Inogen designs, manufactures, and markets innovative portable oxygen concentrators (POCs) and accessories for patients with chronic respiratory conditions like COPD. Its competitive moat comes from patented technology delivering lightweight, compact, and long-lasting POCs, coupled with a strong brand and direct-to-consumer sales model. Inogen is a leader in portable oxygen therapy, enhancing patient mobility and independence through technological innovation.
| Price | $6.54 |
| Market Cap | $177M |
| P/E (Forward) | -25.31 |
| Price/Book | 0.98 |
| Return on Equity | -13.1% |
| Return on Invested Capital | -12.8% |
| Debt/Equity | 9.26 |
| Gross Margin | 44.3% |
| Operating Margin | -9.9% |
| Revenue Growth | 3.4% |
| Free Cash Flow | $-2M |
Inogen, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).